110 related articles for article (PubMed ID: 14666671)
1. Constitutive expression of Rb associated protein 46 (RbAp46) reverts transformed phenotypes of breast cancer cells.
Zhang TF; Yu SQ; Deuel TF; Wang ZY
Anticancer Res; 2003; 23(5A):3735-40. PubMed ID: 14666671
[TBL] [Abstract][Full Text] [Related]
2. RbAp46 inhibits estrogen-stimulated progression of neoplastigenic breast epithelial cells.
Zhang TF; Yu SQ; Wang ZY
Anticancer Res; 2007; 27(5A):3205-9. PubMed ID: 17970062
[TBL] [Abstract][Full Text] [Related]
3. Inducible expression of RbAp46 activates c-Jun NH2-terminal kinase-dependent apoptosis and suppresses progressive growth of tumor xenografts in nude mice.
Zhang TF; Yu SQ; Loggie BW; Wang ZY
Anticancer Res; 2003; 23(6C):4621-7. PubMed ID: 14981905
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
Li GC; Wang ZY
Anticancer Res; 2006; 26(5A):3555-60. PubMed ID: 17094482
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of RbAp46 facilitates stress-induced apoptosis and suppresses tumorigenicity of neoplastigenic breast epithelial cells.
Li GC; Guan LS; Wang ZY
Int J Cancer; 2003 Jul; 105(6):762-8. PubMed ID: 12767060
[TBL] [Abstract][Full Text] [Related]
6. Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1.
Chen GC; Guan LS; Yu JH; Li GC; Choi Kim HR; Wang ZY
Biochem Biophys Res Commun; 2001 Jun; 284(2):507-14. PubMed ID: 11394910
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer.
Thakur A; Rahman KW; Wu J; Bollig A; Biliran H; Lin X; Nassar H; Grignon DJ; Sarkar FH; Liao JD
Mol Cancer Res; 2007 Feb; 5(2):171-81. PubMed ID: 17314274
[TBL] [Abstract][Full Text] [Related]
8. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
9. SUMO-1 overexpression increases RbAp46 protein stability and suppresses cell growth.
Giri R; Yeh HH; Wu CH; Liu HS
Anticancer Res; 2008; 28(6A):3749-56. PubMed ID: 19189660
[TBL] [Abstract][Full Text] [Related]
10. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer.
Lo TL; Yusoff P; Fong CW; Guo K; McCaw BJ; Phillips WA; Yang H; Wong ES; Leong HF; Zeng Q; Putti TC; Guy GR
Cancer Res; 2004 Sep; 64(17):6127-36. PubMed ID: 15342396
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
12. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin.
Zhang TF; Yu SQ; Guan LS; Wang ZY
Anticancer Res; 2003; 23(5A):3575-84. PubMed ID: 14666652
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
[TBL] [Abstract][Full Text] [Related]
15. HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer.
Townson SM; Sullivan T; Zhang Q; Clark GM; Osborne CK; Lee AV; Oesterreich S
Clin Cancer Res; 2000 Sep; 6(9):3788-96. PubMed ID: 10999774
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
17. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
19. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis.
Zhang X; Shen P; Coleman M; Zou W; Loggie BW; Smith LM; Wang Z
Anticancer Res; 2005; 25(1A):369-75. PubMed ID: 15816560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
